Ameliorating effect of Alpinia oxyphylla—Schisandra chinensis herb pair on cognitive impairment in a mouse model of Alzheimer’s disease

Assoc, 2015, Alzheimer's association report 2015 Alzheimer’s disease facts and figures, Alzheimers Dement, 11, 332, 10.1016/j.jalz.2015.02.003 Karran, 2011, The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics, Nat. Rev. Drug Discov., 10, 698, 10.1038/nrd3505 Venkat, 2015, Models and mechanisms of vascular dementia, Exp. Neurol., 272, 97, 10.1016/j.expneurol.2015.05.006 Davies, 1976, Selective loss of central cholinergic neurons in Alzheimer’s disease, Lancet, 2, 1403, 10.1016/S0140-6736(76)91936-X Perry, 1981, Noradrenergic and cholinergic systems in senile dementia of Alzheimer type, Lancet, 2, 149, 10.1016/S0140-6736(81)90327-5 Bartus, 1978, Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine, Pharmacol. Biochem. Behav., 9, 833, 10.1016/0091-3057(78)90364-7 Drachman, 1977, Memory and cognitive function in man: does the cholinergic system have a specific role?, Neurology, 27, 783, 10.1212/WNL.27.8.783 Drachman, 1974, Human memory and the cholinergic system. A relationship to aging?, Arch. Neurol., 30, 113, 10.1001/archneur.1974.00490320001001 Bartus, 2000, On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis, Exp. Neurol., 163, 495, 10.1006/exnr.2000.7397 Auld, 2002, Alzheimer’s disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies, Prog. Neurobiol., 68, 209, 10.1016/S0301-0082(02)00079-5 Lee, 2001, Effect of ginseng saponins on beta-amyloid-suppressed acetylcholine release from rat hippocampal slices, Planta Med., 67, 634, 10.1055/s-2001-17366 Hellstrom-Lindahl, 2000, Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors, Eur. J. Pharmacol., 393, 255, 10.1016/S0014-2999(00)00028-5 Ikonomovic, 2005, Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer’s disease, Arch. Neurol., 62, 425, 10.1001/archneur.62.3.425 Ozturk, 2006, Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer’s disease, Neurobiol. Aging, 27, 1440, 10.1016/j.neurobiolaging.2005.08.024 Albers, 2014, Nuclear 82-kDa choline acetyltransferase decreases amyloidogenic APP metabolism in neurons from APP/PS1 transgenic mice, Neurobiol. Dis., 69, 32, 10.1016/j.nbd.2014.05.008 Resende, 2009, Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation, Cell Commun. Signal., 7, 20, 10.1186/1478-811X-7-20 Stevens, 1981, Scopolamine impairs spatial maze performance in rats, Physiol. Behav., 27, 385, 10.1016/0031-9384(81)90285-7 Snyder, 2014, Microdosing of scopolamine as a cognitive stress test: rationale and test of a very low dose in an at-risk cohort of older adults, Alzheimers Dement, 0, 262, 10.1016/j.jalz.2014.01.009 Piri, 2013, Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats, Neuroscience, 252, 460, 10.1016/j.neuroscience.2013.08.003 Palit, 2015, Reconstituted mother tinctures of Gelsemium sempervirens L. improve memory and cognitive impairment in mice scopolamine-induced dementia model, J. Ethnopharmacol., 159, 274, 10.1016/j.jep.2014.09.008 Bagci, 2016, Anthriscus nemorosa essential oil inhalation prevents memory impairment, anxiety and depression in scopolamine-treated rats, Biomed. Pharmacother., 84, 1313, 10.1016/j.biopha.2016.10.075 Shi, 2015, Protective effect of n-butanol extract from Alpinia oxyphylla on learning and memory impairments, Physiol. Behav., 139, 13, 10.1016/j.physbeh.2014.11.016 Liu, 2014, 5-Hydroxymethylfurfural, an antioxidant agent from Alpinia oxyphylla Miq. improves cognitive impairment in Abeta 1–42 mouse model of Alzheimer’s disease, Int. Immunopharmacol., 23, 719, 10.1016/j.intimp.2014.10.028 Li, 2014, Schisantherin A recovers Abeta-induced neurodegeneration with cognitive decline in mice, Physiol. Behav., 132, 10, 10.1016/j.physbeh.2014.04.046 Mao, 2015, Schisandrin C ameliorates learning and memory deficits by abeta1-42 –induced oxidative stress and neurotoxicity in mice, Phytother. Res., 29, 1373, 10.1002/ptr.5390 Bak, 2017, Effect of rotation preference on spontaneous alternation behavior on Y maze and introduction of a new analytical method, entropy of spontaneous alternation, Behav. Brain Res., 320, 219, 10.1016/j.bbr.2016.12.011 Wang, 2016, Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer’s disease mouse model, Neurobiol. Aging, 38, 32, 10.1016/j.neurobiolaging.2015.10.024 Davis, 1999, Cholinergic markers in elderly patients with early signs of Alzheimer disease, JAMA, 281, 1401, 10.1001/jama.281.15.1401 DeKosky, 2002, Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment, Ann. Neurol., 1, 145, 10.1002/ana.10069 Gilmor, 1999, Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer’s disease, J. Comp. Neurol., 411, 693, 10.1002/(SICI)1096-9861(19990906)411:4<693::AID-CNE13>3.0.CO;2-D Sassin, 2000, Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert, Acta Neuropathol., 100, 259, 10.1007/s004019900178 Araujo, 2005, Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging, Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 411, 10.1016/j.pnpbp.2004.12.008 Zhang, 2012, Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction, Free Radic. Biol. Med., 52, 1443, 10.1016/j.freeradbiomed.2012.01.023 Chambon, 2012, Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication, Eur. J. Pharmacol., 697, 73, 10.1016/j.ejphar.2012.10.011 Li, 2016, Benzoate fraction from Gentiana rigescens Franch alleviates scopolamine-induced impaired memory in mice model in vivo, J. Ethnopharmacol., 193, 107, 10.1016/j.jep.2016.08.001 Nalivaeva, 2016, AChE and the amyloid precursor protein (APP) – cross-talk in Alzheimer’s disease, Chem. Biol. Interact., 59, 301, 10.1016/j.cbi.2016.04.009 Alvarez, 1998, Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer’s fibrils, J. Neurosci., 18, 3213, 10.1523/JNEUROSCI.18-09-03213.1998 De Ferrari, 2001, A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation, Biochemistry, 40, 10447, 10.1021/bi0101392 Dineley, 2015, Nicotinic ACh receptors as therapeutic targets in CNS disorders, Trends Pharmacol. Sci., 36, 96, 10.1016/j.tips.2014.12.002 Chintamaneni, 2017, Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer’s disease, Med. Hypotheses, 101, 17, 10.1016/j.mehy.2017.01.026 Jiang, 2014, M1 muscarinic acetylcholine receptor in Alzheimer’s disease, Neurosci. Bull., 30, 295, 10.1007/s12264-013-1406-z